Dirschka, T

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. [electronic resource] - The British journal of dermatology Apr 2013 - 825-36 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2133

10.1111/bjd.12158 doi


Aged
Aged, 80 and over
Aminolevulinic Acid--administration & dosage
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Keratosis, Actinic--drug therapy
Long-Term Care
Male
Middle Aged
Photochemotherapy--methods
Photosensitizing Agents--administration & dosage
Prospective Studies
Recurrence
Treatment Outcome